Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1974 May;9(5):839–842. doi: 10.1128/iai.9.5.839-842.1974

Leukocyte Migration Inhibition in Chorioretinitis

Walter L Henley 1, Irving H Leopold 1, Sirje Okas 1
PMCID: PMC414895  PMID: 4824633

Abstract

Leukocyte migration inhibition (LMI) by choroid, retina, and uveal tract antigens was studied in patients with active and quiescent chorioretinal disease. LMI by retina was more frequent in both groups of patients, occurring in 9 of 16 patients with active disease and in 8 to 15 patients with disease in remission. Choroid was tested in 15 patients with active inflammation and led to LMI in 7 of them when they were off steroid therapy; it produced LMI in 3 of 13 patients whose disease appeared healed. Significant LMI was detected in three of six patients with active chorioretinitis and in one of five patients with evidence of past chorioretinopathy when their cells were tested with antigen made from pooled uveal tract tissue. The LMI test, regarded as an indicator of cell-mediated immunity, is briefly discussed. LMI by retina in over one-half of patients with chorioretinopathies appears to be a secondary event, and cellular immunity to retina may be of pathophysiological importance in the chronicity of the disorder.

Full text

PDF
839

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bendixen G. Specific inhibition of the in vitro migration of leucocytes in ulcerative colitis and Crohn's disease. Scand J Gastroenterol. 1967;2(3):214–221. doi: 10.3109/00365526709180072. [DOI] [PubMed] [Google Scholar]
  2. Dardenne M., Zabriskie J., Back J. F. Streptococcal sensitivity in chronic glomerulonephritis. Lancet. 1972 Jan 15;1(7742):126–128. doi: 10.1016/s0140-6736(72)90684-8. [DOI] [PubMed] [Google Scholar]
  3. Gaines J. D., Araujo F. G., Krahenbuhl J. L., Remington J. S. Simplified in vitro method for measuring delayed hypersensitivity to latent intracellular infection in man (toxoplasmosis). J Immunol. 1972 Jul;109(1):179–182. [PubMed] [Google Scholar]
  4. Henley W. L., Leopold I. H., Okas S., Shore B. Leukocyte migration inhibition in chronic ophthalmic disorders. 5. Diabetic retinopathy and the effect of photocoagulation. Am J Ophthalmol. 1973 Aug;76(2):279–283. doi: 10.1016/0002-9394(73)90175-x. [DOI] [PubMed] [Google Scholar]
  5. Henley W. L., Shore B., Leopold I. H. Inhibition of leucocyte migration by corneal antigen in chronic viral keratitis. Nat New Biol. 1971 Sep 22;233(38):115–115. doi: 10.1038/newbio233115a0. [DOI] [PubMed] [Google Scholar]
  6. Henson P. M. Mechanisms of release of granule enzymes from human neutrophils phagocytosing aggregated immunoglobulin. An electron microscopic study. Arthritis Rheum. 1973 Mar-Apr;16(2):208–216. doi: 10.1002/art.1780160211. [DOI] [PubMed] [Google Scholar]
  7. Herman J. H., Dennis M. V. Immunopathologic studies in relapsing polychondritis. J Clin Invest. 1973 Mar;52(3):549–558. doi: 10.1172/JCI107215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. In vitro methods in cell-mediated immunity: a progress report. Cell Immunol. 1973 Mar;6(3):331–347. doi: 10.1016/0008-8749(73)90034-8. [DOI] [PubMed] [Google Scholar]
  9. Krahenbuhl J. L., Gaines J. D., Remington J. S. Lymphocyte transformation in human toxoplasmosis. J Infect Dis. 1972 Mar;125(3):283–288. doi: 10.1093/infdis/125.3.283. [DOI] [PubMed] [Google Scholar]
  10. Miller J., Smith M. G., Mitchell C. G., Reed W. D., Eddleston A. L., Williams R. Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis. Lancet. 1972 Aug 12;2(7772):296–297. doi: 10.1016/s0140-6736(72)92904-2. [DOI] [PubMed] [Google Scholar]
  11. Papageorgiou P. S., Sorokin C. F., Kouzoutzakoglou K., Bonforte R. J., Workman P. L., Glade P. R. Host responses to Epstein-Barr virus and cytomegalovirus infection in leprosy. Infect Immun. 1973 Apr;7(4):620–624. doi: 10.1128/iai.7.4.620-624.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Remington J. S., Miller M. J., Brownlee I. IgM antibodies in acute toxoplasmosis. II. Prevalence and significance in acquired cases. J Lab Clin Med. 1968 May;71(5):855–866. [PubMed] [Google Scholar]
  13. Rocklin R. E., Sheremata W. A., Feldman R. G., Kies M. W., David J. R. The Guillain-Barré syndrome and multiple sclerosis. In vitro cellular responses to nervous-tissue antigens. N Engl J Med. 1971 Apr 15;284(15):803–808. doi: 10.1056/NEJM197104152841501. [DOI] [PubMed] [Google Scholar]
  14. SANDS J. H., PALMER P. P., MAYCOCK R. L., GREGER W. P. Evidence for serologic hyper-reactivity in sarcoidosis. Am J Med. 1955 Sep;19(3):401–409. doi: 10.1016/0002-9343(55)90128-5. [DOI] [PubMed] [Google Scholar]
  15. Topilsky M., Siltzbach L. E., Williams M., Glade P. R. Lymphocyte response in sarcoidosis. Lancet. 1972 Jan 15;1(7742):117–120. doi: 10.1016/s0140-6736(72)90680-0. [DOI] [PubMed] [Google Scholar]
  16. Winkelstein A. Mechanisms of immunosuppression: effects of cyclophosphamide on cellular immunity. Blood. 1973 Feb;41(2):273–284. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES